Phase 1 PK Study of XOMA 3AB

NCT01357213 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Botulism

Interventions

DRUG: XOMA 3AB
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)